Condition

Advanced Non-squamous Non-small-cell Lung Cancer

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 9 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials9
Recruiting2
Common interventions25
Lead sponsors shown8
Advertisement

Clinical trials

9 shown
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL CancerNCT06463665 · 2024-09-26
RECRUITING
JAB-21822 Combined With JAB-3312 Compared SOC in the First Line for Treatment of Advanced Non-small Cell Lung Cancer With KRAS p.G12C MutationNCT06416410 · 2024-08-07
RECRUITING
Emulation of the CheckMate 017/057 (NCT01642004 and NCT01673867) Trials Using Specialty Oncology Electronic Health Records DatabasesNCT07485166 · 2026-03-12
ACTIVE_NOT_RECRUITING
A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or AmplificationNCT06585488 · 2024-12-13
TERMINATED
Efficacy and Safety of Nab-paclitaxel-Lenvatinib-Pembrolizumab as Second-line Treatment in Advanced NSCLC PatientsNCT06028633 · 2023-10-01
NOT_YET_RECRUITING
A Study of Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Advanced NSCLCNCT04959981 · 2021-09-02
COMPLETED
A Study to Compare the Similarity in Efficacy and Safety Between TRS003 and China-approved Bevacizumab® in NSCLCNCT04416035 · 2020-08-17
UNKNOWN
Pemetrexed Plus Apatinib Maintenance Treatment in Patients With Non-squamous Non-small Cell Lung Cancer Patients Who Have Not Progressed After 4 Cycles of Induction Chemotherapy of Pemetrexed in Combination With Platinum-based RegimenNCT03792503 · 2019-02-01
WITHDRAWN
Efficacy and Safety of Maintenance Apatinib Combined With Pemetrexed in Advanced Non-squamous Non-small Cell Lung Cancer PatientsNCT03190239 · 2017-07-15
WITHDRAWN

Common interventions

Trial status mix

RECRUITING2
WITHDRAWN2
ACTIVE_NOT_RECRUITING1
COMPLETED1
NOT_YET_RECRUITING1
TERMINATED1
UNKNOWN1

Phase mix

PHASE23
PHASE12
PHASE32
PHASE41
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.